Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation
- 1 January 2002
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 46 (1), 133-137
- https://doi.org/10.1067/mjd.2002.117718
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tissue Plasminogen Activator for Treatment of Livedoid VasculitisMayo Clinic Proceedings, 1992
- Thrombotic skin disease as a marker of the anticardiolipin syndrome: Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activityJournal of the American Academy of Dermatology, 1989
- Antithrombotic treatment in livedo vasculitisJournal of the American Academy of Dermatology, 1988
- Cutaneous manifestations associated with the presence of the lupus anticoagulant: A report of two cases and a review of the literatureJournal of the American Academy of Dermatology, 1986
- Minidose heparin therapy for vasculitis of atrophie blancheJournal of the American Academy of Dermatology, 1983
- Antiplatelet therapy in atrophie blanche and livedo vasculitisJournal of the American Academy of Dermatology, 1982
- Atrophie blanche: Report of two patients treated with aspirin and dipyridamoleJournal of the American Academy of Dermatology, 1982
- Livedo Reticularis with UlcerationsCirculation, 1956
- LIVEDO RETICULARIS WITH SUMMER ULCERATIONS REPORT OF CASE TREATED WITH LONG‐TERM ANTICOAGULATION THERAPY.Acta Medica Scandinavica, 1956
- Livedo reticularis: A peripheral arteriolar diseaseAmerican Heart Journal, 1941